Skip to main content
Advertisement
Browse Subject Areas
?

Click through the PLOS taxonomy to find articles in your field.

For more information about PLOS Subject Areas, click here.

< Back to Article

Table 1.

Summary of cost components included in the C4P tool.

More »

Table 1 Expand

Table 2.

Baseline characteristics of demonstration project countries.

More »

Table 2 Expand

Table 3.

HPV vaccination coverage and drop-out rates of demonstration project districts.

More »

Table 3 Expand

Table 4.

HPV vaccine economic and financial costs of demonstration project countries, 2014 US$.

More »

Table 4 Expand

Table 5.

Breakdown of economic and financial cost per HPV vaccine dose in demonstration project countries, 2014 US$.

More »

Table 5 Expand

Table 6.

Economic and financial costs per dose of service delivery cost component (2014 US$).

More »

Table 6 Expand

Fig 1.

Target population and financial cost per dose in demonstration project countries.

US$, United States dollars. Blue curve represents theoretical cost per girl in the target population if countries were to spend exactly the amount provided by the Gavi demonstration project first year grant. The points (denoted by “x”) represent the actual financial cost per girl in the target population from Gavi demonstration projects.

More »

Fig 1 Expand